Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Research & Development (2018 - 2026)

Alector's (ALEC) quarterly Research & Development came in at $19.5 million in Q2 2026, down 29.52% year-over-year from $27.6 million in Q2 2025, and up 8.98% quarter-over-quarter from $17.9 million in Q1 2026.

Analysis

Alector (ALEC) Research & Development (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Research & Development for 9 consecutive years, with $19.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Research & Development fell 29.52% year-over-year to $19.5 million in Q2 2026; TTM through Jun 2026 was $99.1 million, a 36.34% decrease from a year earlier, with the FY2025 full-year figure at $123.1 million, down 33.81% from the prior year.
  • Research & Development was $19.5 million for Q2 2026 at Alector, up from $17.9 million in the prior quarter.
  • Over five years, Research & Development peaked at $54.5 million in Q2 2022 and troughed at $17.9 million in Q1 2026.
  • A 5-year average of $41.6 million and a median of $46.3 million in 2023 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development grew 15.98% in 2022 and plunged 46.92% in 2026, its largest moves.
  • Over 5 years, Research & Development stood at $54.5 million in 2022, then dropped by 12.42% to $47.7 million in 2023, then retreated by 2.64% to $46.5 million in 2024, then tumbled by 30.13% to $32.5 million in 2025, then tumbled by 40.05% to $19.5 million in 2026.
  • The last three Research & Development figures came in at $19.5 million (Q2 2026), $17.9 million (Q1 2026), and $32.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 1.87 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 1.76 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 993.80 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.63 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -486.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 651.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 413.13 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 529.60 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 210.03 Mn
10 Alector 274.68 Mn 101.88 Mn - 19.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.46 Mn
Mar 31, 2026 17.86 Mn
Dec 31, 2025 32.46 Mn
Sep 30, 2025 29.35 Mn
Jun 30, 2025 27.61 Mn
Mar 31, 2025 33.64 Mn
Dec 31, 2024 46.46 Mn
Sep 30, 2024 48.00 Mn
Jun 30, 2024 46.31 Mn
Mar 31, 2024 45.17 Mn
Dec 31, 2023 47.72 Mn
Sep 30, 2023 46.33 Mn
Jun 30, 2023 46.18 Mn
Mar 31, 2023 51.89 Mn
Dec 31, 2022 54.49 Mn
Sep 30, 2022 48.35 Mn
Jun 30, 2022 54.53 Mn
Mar 31, 2022 53.04 Mn
Dec 31, 2021 52.79 Mn
Sep 30, 2021 43.07 Mn